Return On Assets in % of Tvardi Therapeutics, Inc. from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q3 2014 to Q3 2025.
  • Tvardi Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -166 %, a 188% decline year-over-year.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2024 was -114 %, a 26.9% decline from 2023.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2023 was -89.6 %, a 122% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2022 was -40.4 %, a 7.79% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -166 -108 -188% 01 Jul 2025 30 Sep 2025
Q2 2025 -154 -83 -117% 01 Apr 2025 30 Jun 2025
Q1 2025 -154 -71.6 -86.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -114 -24.2 -26.9% 01 Oct 2024 31 Dec 2024
Q3 2024 -57.7 +21.9 +27.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -70.9 -5.52 -8.45% 01 Apr 2024 30 Jun 2024
Q1 2024 -82.5 -39 -89.6% 01 Jan 2024 31 Mar 2024
Q4 2023 -89.6 -49.2 -122% 01 Oct 2023 31 Dec 2023
Q3 2023 -79.6 -40.8 -105% 01 Jul 2023 30 Sep 2023
Q2 2023 -65.4 -36.6 -127% 01 Apr 2023 30 Jun 2023
Q1 2023 -43.5 -3.02 -7.46% 01 Jan 2023 31 Mar 2023
Q4 2022 -40.4 -2.92 -7.79% 01 Oct 2022 31 Dec 2022
Q3 2022 -38.9 -48.7 -494% 01 Jul 2022 30 Sep 2022
Q2 2022 -28.8 -32.5 -866% 01 Apr 2022 30 Jun 2022
Q1 2022 -40.5 -47.2 -704% 01 Jan 2022 31 Mar 2022
Q4 2021 -37.5 -41.8 -973% 01 Oct 2021 31 Dec 2021
Q3 2021 9.86 +63.1 01 Jul 2021 30 Sep 2021
Q2 2021 3.75 +57.4 01 Apr 2021 30 Jun 2021
Q1 2021 6.7 +60.5 01 Jan 2021 31 Mar 2021
Q4 2020 4.3 +56.4 01 Oct 2020 31 Dec 2020
Q3 2020 -53.2 -2.42 -4.76% 01 Jul 2020 30 Sep 2020
Q2 2020 -53.6 -6.64 -14.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -53.8 -9.43 -21.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -52.1 -4.64 -9.78% 01 Oct 2019 31 Dec 2019
Q3 2019 -50.8 +0.14 +0.28% 01 Jul 2019 30 Sep 2019
Q2 2019 -47 +9.98 +17.5% 01 Apr 2019 30 Jun 2019
Q1 2019 -44.4 +7.84 +15% 01 Jan 2019 31 Mar 2019
Q4 2018 -47.4 +16 +25.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -51 +28.2 +35.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -56.9 +28.3 +33.2% 01 Apr 2018 30 Jun 2018
Q1 2018 -52.2 +46.3 +47% 01 Jan 2018 31 Mar 2018
Q4 2017 -63.5 +4.31 +6.36% 01 Oct 2017 31 Dec 2017
Q3 2017 -79.2 -32.6 -69.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -85.2 -49.2 -136% 01 Apr 2017 30 Jun 2017
Q1 2017 -98.5 -66 -203% 01 Jan 2017 31 Mar 2017
Q4 2016 -67.8 -37.6 -124% 01 Oct 2016 31 Dec 2016
Q3 2016 -46.6 -18.1 -63.8% 01 Jul 2016 30 Sep 2016
Q2 2016 -36 +2.96 +7.59% 01 Apr 2016 30 Jun 2016
Q1 2016 -32.5 -0.55 -1.72% 01 Jan 2016 31 Mar 2016
Q4 2015 -30.2 -2.71 -9.85% 01 Oct 2015 31 Dec 2015
Q3 2015 -28.4 +0.02 +0.07% 01 Jul 2015 30 Sep 2015
Q2 2015 -39 01 Apr 2015 30 Jun 2015
Q1 2015 -32 01 Jan 2015 31 Mar 2015
Q4 2014 -27.5 01 Oct 2014 31 Dec 2014
Q3 2014 -28.5 01 Jul 2014 30 Sep 2014

Tvardi Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -114 -24.2 -26.9% 01 Jan 2024 31 Dec 2024
2023 -89.6 -49.2 -122% 01 Jan 2023 31 Dec 2023
2022 -40.4 -2.92 -7.79% 01 Jan 2022 31 Dec 2022
2021 -37.5 -41.8 -973% 01 Jan 2021 31 Dec 2021
2020 4.3 +56.4 01 Jan 2020 31 Dec 2020
2019 -52.1 -4.64 -9.78% 01 Jan 2019 31 Dec 2019
2018 -47.4 +16 +25.3% 01 Jan 2018 31 Dec 2018
2017 -63.5 +4.31 +6.36% 01 Jan 2017 31 Dec 2017
2016 -67.8 -37.6 -124% 01 Jan 2016 31 Dec 2016
2015 -30.2 -2.71 -9.85% 01 Jan 2015 31 Dec 2015
2014 -27.5 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.